INTERNATIONAL PATENT: AIMED BIO INC., (주)에임드바이오, SAMSUNG BIOLOGICS CO., LTD., 삼성바이오로직스 주식회사 FILES APPLICATION FOR "LINKER-DRUG CONJUGATE AND ANTIBODY-DRUG CONJUGATE BOTH COMPRISING SILATECAN DERIVATIVE"

Posted On: 2026-02-18

GENEVA, Feb. 18 -- AIMED BIO INC. ((Munjeong-dong, MK Tower), 11F, 67 Jeongui-roSongpa-guSeoul 05835), (주)에임드바이오 (서울특별시송파구정의로 67, 11층 (문정동, 엠케이타워)), SAMSUNG BIOLOGICS CO., LTD. (300 Songdobio-daeroYeonsu-guIncheon 21987), 삼성바이오로직스 주식회사 (인천광역시연수구송도바이오대로 300) filed a patent application (PCT/KR2025/012064) for "LINKER-DRUG CONJUGATE AND ANTIBODY-DRUG CONJUGATE BOTH COMPRIS...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: AIMED BIO INC., (주)에임드바이오, SAMSUNG BIOLOGICS CO., LTD., 삼성바이오로직스 주식회사 FILES APPLICATION FOR "LINKER-DRUG CONJUGATE AND ANTIBODY-DRUG CONJUGATE BOTH COMPRISING SILATECAN DERIVATIVE"